SUPPLEMENT
FY2026 — Additional analyst information
FY2026PDF · 18 pages580 KB
This pack has been prepared to aid discussion and provide further supplementary information only and has not been subject to an external review or audit # Public -- 1 of 18 -- CUSTOMERS PER ENTITY Life Policyholders June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 465,203 459,473 453,418 450,866 449,211 449,300 447,690 449,130 449,020 449,378 448,313 445,813 446,713 452,561 446,475 Invest Invest - DRO 136,969 137,008 137,297 137,441 137,503 137,718 137,189 135,819 134,721 133,741 132,817 131,244 129,606 127,831 124,135 Invest - Other 260,765 251,084 241,608 236,055 229,871 225,414 221,273 216,479 212,161 206,778 201,210 195,231 192,615 189,210 185,025 Umbrella (lives) 121,945 114,848 101,448 98,188 92,178 Umbrella schemes 569 548 511 503 480 HealthyCompany 183,995 Group (lives) 697,760 652,168 702,521 707,154 711,051 707,756 711,161 680,754 584,081 562,769 576,450 562,440 578,035 551,219 544,443 Group schemes 2,550 2,531 2,548 2,581 2,616 2,647 2,663 2,666 2,793 2,844 2,827 2,825 2,797 2,740 2,771 Life NB API 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to 6 months to 12 months to R million June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 2,811 1,441 2,733 1,441 2,778 1,444 2,663 1,355 2,362 1,204 2,072 1,068 2,126 1,165 2,215 Group 137 67 87 23 164 75 175 130 181 64 193 94 160 75 97 Umbrella 278 128 383 192 626 HealthyCompany 18 Invest - Recurring 1,886 977 1,624 867 1,673 851 1,551 796 1,428 737 1,167 573 1,164 686 1,221 Invest - Single API1 1,979 983 1,806 867 1,627 778 1,500 708 1,493 782 1,570 744 1,508 671 1,382 Total Life API 7,109 3,596 6,633 3,390 6,868 3,148 5,889 2,989 5,463 2,786 5,001 2,478 4,958 2,597 4,915 1 API shown at 10% of Single premium Health Members June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 DHMS - Keycare 170,122 186,366 189,775 204,847 207,934 226,848 225,517 232,988 232,055 234,421 235,841 230,960 232,714 243,046 240,140 DHMS - Non-Keycare 1,212,062 1,182,021 1,169,413 1,154,532 1,152,395 1,147,016 1,149,861 1,142,556 1,135,853 1,118,591 1,111,545 1,099,553 1,111,079 1,108,674 1,110,401 In-House Schemes 373,811 366,017 370,608 356,504 354,944 321,333 319,813 321,838 318,246 316,973 321,613 321,767 319,974 317,408 316,410 Total 1,755,995 1,734,404 1,729,796 1,715,883 1,715,273 1,695,197 1,695,191 1,697,382 1,686,154 1,669,985 1,668,999 1,652,280 1,663,767 1,669,128 1,666,951 Health Lives June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 DHMS - Keycare 278,196 308,665 315,406 343,648 350,038 385,906 384,759 398,397 397,595 401,307 404,984 400,108 403,392 420,869 415,436 DHMS - Non-Keycare 2,457,073 2,416,457 2,401,304 2,391,556 2,394,452 2,402,336 2,413,851 2,412,595 2,406,528 2,383,486 2,375,082 2,358,232 2,381,735 2,387,237 2,394,336 In-House Schemes 840,694 824,525 813,719 800,093 798,933 710,485 707,406 710,427 704,472 699,342 707,293 704,749 698,534 689,688 686,114 Total 3,575,963 3,549,647 3,530,429 3,535,297 3,543,423 3,498,727 3,506,016 3,521,419 3,508,595 3,484,135 3,487,359 3,463,089 3,483,661 3,497,794 3,495,886 Vitality SA June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 20222 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Total Vitality Health, Vitality Drive and Vitality Money programme lives 3,463,461 3,306,992 3,157,572 3,038,785 2,922,347 2,822,972 2,652,877 2,498,048 2,348,834 2,242,401 2,163,411 2,122,453 2,065,868 2,060,011 1,987,237 2 restated to include for LA wellness figures VitalityHealth Members June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 143,023 141,965 141,822 141,014 140,400 138,278 135,117 129,568 124,395 117,007 113,189 108,955 105,915 104,997 101,702 SME 347,961 347,827 349,465 344,320 340,983 327,876 310,624 285,865 263,216 238,540 222,961 211,949 212,305 209,509 201,960 Corporate 141,479 136,345 131,885 128,241 120,685 112,941 108,191 102,823 99,578 89,881 86,149 80,514 81,124 78,050 70,583 Trust and Cost Plus 20,352 19,668 18,496 20,198 20,237 16,448 16,339 14,511 8,698 3,944 2,731 2,639 - - - Lite 1,034 80 - - - - - - - - - - - - - Total 653,849 645,885 641,668 633,773 622,305 595,543 570,271 532,767 495,887 449,372 425,030 404,057 399,344 392,556 374,245 VitalityHealth Lives June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Individual 269,634 265,301 262,888 261,481 260,210 256,527 250,551 238,629 227,684 212,896 204,890 195,996 188,976 186,559 179,811 SME 546,885 547,180 550,925 545,424 541,111 522,753 496,299 460,442 429,110 395,777 374,179 357,768 356,907 353,763 342,431 Corporate 222,826 217,226 210,225 202,151 191,015 178,163 171,364 163,120 158,890 148,654 143,905 135,218 135,440 131,991 120,157 Trust and Cost Plus 35,841 34,671 32,739 35,214 35,163 27,349 26,854 22,673 15,903 6,509 4,066 3,956 - - - Lite 1,250 99 - - - - - - - - - - - - - Total 1,076,436 1,064,477 1,056,777 1,044,270 1,027,499 984,792 945,068 884,864 831,587 763,836 727,040 692,938 681,323 672,313 642,399 VitalityLife Policies June 2026 December 2025 June 2025 December 20243 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Policies 890,028 837,243 781,548 723,213 679,382 646,564 622,451 593,322 565,778 535,281 517,913 493,970 474,890 458,675 434,678 3 December 2024 has been restated VitalityLife Lives June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Lives4 1,006,514 957,864 903,996 852,154 810,050 782,296 764,699 735,137 702,105 669,139 647,020 617,051 594,799 577,965 549,526 4 restated to include unique lives only Discovery Insure Policies June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Policies 210,103 208,123 208,192 213,762 214,297 215,297 211,223 214,315 213,453 212,570 202,335 191,936 178,517 169,920 159,171 Discovery Bank June 2026 December 2025 June 2025 December 2024 June 2024 December 2023 June 2023 December 2022 June 2022 December 2021 June 2021 December 2020 June 2020 December 2019 June 2019 Primary Clients 1,567,789 1,402,626 1,246,817 1,092,386 958,055 825,069 702,131 581,457 470,220 385,177 331,088 287,183 206,810 61,731 1,476 Total Accounts 3,766,907 3,365,688 2,995,078 2,608,023 2,271,703 1,933,839 1,625,912 1,312,970 1,023,790 793,215 648,546 521,081 357,416 141,660 3,740 2 Membership # Public -- 2 of 18 -- VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE June 2026 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (585) (3,186) (1,741) (3,915) (9,427) Value of In Force 2,091 3,741 2,295 4,477 12,604 Cost of Capital (51) (86) (60) (159) (356) 1,455 469 494 403 2,821 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 2,057 2,787 2,078 3,676 10,598 Cost of Capital (50) (86) (56) (145) (337) 2,007 2,701 2,022 3,531 10,261 December 2025 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (286) (1,622) (879) (1,925) (4,712) Value of In Force 926 1,966 1,161 2,181 6,234 Cost of Capital (23) (43) (29) (71) (166) 617 301 253 185 1,356 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 922 1,475 1,093 1,897 5,387 Cost of Capital (23) (43) (28) (70) (164) 899 1,432 1,065 1,827 5,223 June 2025 VNB at Point of Sale R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Acquisition Costs and Initial strain (537) (2,937) (1,653) (3,622) (8,749) Value of In Force 1,632 3,472 2,324 3,775 11,203 Cost of Capital (45) (74) (62) (119) (300) 1,050 461 609 34 2,154 New business contribution to value of in force at valuation date R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Value of In Force 1,597 2,449 2,210 3,404 9,660 Cost of Capital (43) (74) (63) (110) (290) 1,554 2,375 2,147 3,294 9,370 3 Value of New Business # Public -- 3 of 18 -- EV RECONCILIATION TO INCOME STATEMENT for the year ended 30 June 2026 R million Embedded Value Earnings Value of In- Force Cost of required Capital Impact on Income Statement Adjustment to Shareholders Funds Statement of Changes in Equity Total profit from new business (at point of sale) 2,821 10,411 (356) (7,234) - - - Health and Vitality 1,455 1,953 (51) (447) - - - Life 469 2,703 (86) (2,148) - - - VitalityHealth 494 2,051 (60) (1,497) - - - VitalityLife 403 3,704 (159) (3,142) - - Profit from existing business Expected return 10,947 1,175 (5) 9,777 - - - Health and Vitality 3,823 282 15 3,526 - - Expected transfer from VIF to net worth - (3,526) - 3,526 - - Unwinding of the risk discount rate 3,823 3,808 15 - - - - Life 4,931 1,637 20 3,274 - - Expected transfer from VIF to net worth - (3,274) - 3,274 - - Unwinding of the risk discount rate 4,931 4,911 20 - - - - VitalityHealth 1,186 (809) (31) 2,026 - - Expected transfer from VIF to net worth - (2,026) - 2,026 - - Unwinding of the risk discount rate 1,186 1,217 (31) - - - - VitalityLife 1,007 65 (9) 951 - - Expected transfer from VIF to net worth - (951) - 951 - - Unwinding of the risk discount rate 1,007 1,016 (9) - - - Change in methodology and assumptions 5,330 2,223 (116) 3,223 - - - Health and Vitality 669 646 23 - - - - Life 5,162 4,547 (100) 715 - - - VitalityHealth (489) (503) 14 - - - - VitalityLife (12) (2,467) (53) 2,508 - - Experience variances 3,116 1,198 78 1,840 - - - Health and Vitality 1,216 717 (16) 515 - - - Life 1,222 474 9 739 - - - VitalityHealth 520 (90) 85 525 - - - VitalityLife 158 97 - 61 - - Increase in goodwill and intangibles (344) - - - (344) - Non-covered business 2,819 - - 2,819 - - Non-recurring expenses (280) - - (280) - - Acquisition costs (61) 3 - (64) - - Finance costs (3,018) - - (3,018) - - Other (74) - - 1 (75) - Foreign Exchange Rate Movements (4,803) (3,732) 133 1,545 404 (3,153) Intangibles 404 - - - 404 - Other (5,207) (3,732) 133 1,545 - (3,153) Return on shareholders' funds 1,433 - - 1,478 - (45) Unrealised gain on investments and realised gain on investments transferred to income statement 1,029 - - 1,074 - (45) Health and Vitality investment income 105 - - 105 - - Life investment income 299 - - 299 - - VitalityHealth investment income - - - - - - VitalityLife investment income - - - - - - Amortisation of Intangibles (41) - - (636) 595 - Amortisation of intangibles from business combinations (41) - - (65) 24 - Amortisation of systems intangibles - - - (571) 571 - VitalityHealth and VitalityLife DAC and unemployment reserve - - - (3) 3 - Reversal of 1 Discovery Place IFRS 16 financial lease accounting - - - 1,550 (1,550) - Life assets under insurance contracts - - - 2,766 (10,611) 7,845 VitalityLife net assets under insurance contracts - - - (544) (28) 572 VitalityHealth Insurance Acquisition Cash Flow (IACF) asset - - - (18) 18 - VitalityHealth FinRe - - - (53) 53 - Equity settled share based payment mark-to-market adjustment - - - 69 (69) - Embedded value earnings 17,845 11,278 (266) 13,218 (11,604) 5,219 Adjustment to Shareholders' Funds: Change in: * VitalityHealth Insurance Acquisition Cash Flow (IACF) asset 71 Intangibles & Goodwill 583 Life net assets under insurance contracts (10,611) VitalityLife net assets under insurance contracts (28) 1 DP IFRS 16 financial lease accounting (1,550) Equity settled share based payment mark-to-market adjustment (69) * The total change in the net assets under insurance contracts consists of the change in the Negative Rand Reserve (NRR), which is zeroised in the embedded value. The change in the NRR is split between the Income Statement and the change in the Insurance Finance Reserve, which flows through the Statement of Changes in Equity (SOCIE). 4 EV recon # Public -- 4 of 18 -- EV BUILD-UP PER ENTITY for the year ended 30 June 2026 R million Health and Vitality Life and Invest VitalityHealth VitalityLife Other Total Value of in-force business at 30 June 2025 27,447 41,255 17,869 14,944 - 101,515 Expected return (in-force business) 3,721 4,779 1,093 884 - 10,477 Release of profits (in-force business) (3,526) (3,274) (2,026) (951) - (9,777) Value of new business 2,040 3,655 2,235 4,318 - 12,248 Expected return (new business) 102 152 93 123 - 470 Release of profits (new business) (138) (1,038) (244) (773) - (2,193) Experience variances 701 483 (5) 97 - 1,276 Methodology changes 669 4,447 (489) (2,520) - 2,107 Other - 3 (1,946) (1,653) - (3,596) Value of in-force business at 30 June 2026 31,016 50,462 16,580 14,469 - 112,527 Shareholders’ funds per Balance Sheet 2,069 44,345 10,155 6,919 19,173 82,661 Adjustment to shareholders' funds - (31,944) (5,049) (11,695) (3,576) (52,264) Embedded value at 30 June 2026 33,085 62,863 21,686 9,693 15,597 142,924 5 EV Buildup per Entity # Public -- 5 of 18 -- COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO SHAREHOLDERS' FUNDS ON PUBLISHED BASIS R million June 2026 June 2025 1. Assets under insurance contracts Discovery Life positive liabilities not netted off with negative liabilities: 587 571 Discovery Life long term reserves in respect of policies with net negative liabilities: (46,786) (31,656) Working capital 211 210 Discovery Life liability for incurred claims (LIC) 8,294 7,873 Total Assets under insurance contracts: (37,694) (23,002) 2. Negative liabilites not included under assets under insurance contracts Negative reserve in respect of Invest business (8,044) (7,617) DAC and DRL in respect of Invest business (905) (811) (8,949) (8,428) 3. Components to be zeroised based on the Method of Distributable Cashflows: Discovery Life long term reserves in respect of policies with net negative liabilities: (46,786) (31,656) Liabilities under reinsurance contracts* 1,090 432 Negative reserve in respect of Invest business (8,044) (7,617) DAC and DRL in respect of Invest business (905) (811) Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 11,220 6,705 Liabilities off set against Negative reserve before zeroisation 11,481 11,614 (31,944) (21,333) * This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the method of distributable cashflows. 4. Other adjustments to published Shareholders' funds VitalityLife net assets under insurance contracts (11,691) (11,663) VitalityHealth Insurance Acquisition Cash Flow (IACF) asset (5,049) (5,120) VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) (4) (7) Goodwill (2,689) (3,012) Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance Company joint venture (556) (813) Net preference share capital (779) (779) Reversal of 1 Discovery Place IFRS 16 financial lease accounting - 1,550 Equity settled share based payment mark-to-market adjustment 448 517 Adjustment to Shareholders' funds from published basis (52,264) (40,660) The "Reversal of 1 Discovery Place IFRS 16 financial lease accounting" adjustment has reduced from R1.55 billion at 30 June 2025 to nil at 30 June 2026 following the purchase of the 1 Discovery Place building. The historical EV adjustment is no longer required and has been replaced by a once-off gain of R1.07 billion (net of tax) recognised on the termination of the lease arrangement, which is reflected in the Shareholders' funds and therefore forms part of the Adjusted net worth. 6 EV Adjustment to SH funds # Public -- 6 of 18 -- RECONCILIATION TO THE REQUIRED CAPITAL for the year ended 30 June 2026 R million Health and Vitality Life and Invest VitalityHealth VitalityLife Total Opening - 30 June 2025 1,286 29,349 4,761 13,050 48,446 - Methodology and Basis Changes - 5,826 - 612 6,438 - Expected release on in-force at start of period (34) (668) (155) (584) (1,441) - Impact of new business written 136 1,105 504 2,278 4,023 - Other changes* (60) 1,827 (329) - 1,438 - Exchange rate movements - - (512) (1,540) (2,052) Change in Required Capital 42 8,090 (492) 766 8,406 Closing - 30 June 2026 1,328 37,439 4,269 13,816 56,852 *This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required capital. This component of the expected yield curve unwind is shown separately from the expected release for information purposes only. 7 Recon of Required Capital # Public -- 7 of 18 -- BREAKDOWN OF INVEST AND UMBRELLA ASSETS UNDER ADMINISTRATION R million Invest Umbrella December 2021 127,632 June 2022 121,737 December 2022 130,830 June 2023 140,378 December 2023 144,810 June 2024 154,653 17,074 December 2024 166,915 18,196 June 2025 178,744 22,487 December 2025 199,820 25,436 June 2026 204,543 26,472 8 Invest and Umbrella AUA # Public -- 8 of 18 -- SA SA SA SA SA UK UK ALL OTHER SEGMENT IFRS R million HEALTH LIFE INVEST INSURE BANK HEALTH LIFE SEGMENTS TOTAL TOTAL 30 June 2026 Income statement Insurance revenue 803 19,601 4,796 6,448 - 20,611 9,184 (1) 61,442 - 61,442 - Contracts measured under the General measurement model/Variable fee approach - 15,847 4,796 - - - 9,184 - 29,827 - 29,827 - Contracts measured under Premium allocation approach 803 3,754 - 6,448 - 20,611 - (1) 31,615 - 31,615 Insurance service expenses (556) (16,059) (3,086) (5,588) - (18,046) (8,250) 8 (51,577) - (51,577) - Claims and benefits (378) (11,576) (702) (2,923) - (11,545) (3,687) 10 (30,801) - (30,801) - Insurance service expense and other (109) (1,987) (1,432) (1,672) - (4,328) (1,136) (2) (10,666) - (10,666) - Insurance acquisition cash flows (69) (2,496) (952) (993) - (2,173) (3,427) - (10,110) - (10,110) Tax specific to policyholder tax funds - - (116) - - - - - (116) 116 - Insurance service result (pre-reinsurance) 247 3,542 1,594 860 - 2,565 934 7 9,749 116 9,865 Net expenses from reinsurance contracts (2) (606) - (117) - 2 (395) (6) (1,124) - (1,124) - Reinsurance expense (3) (3,971) - (117) - (4) (9,303) - (13,398) - (13,398) - Insurance claims recovered from reinsurers 1 3,365 - - - 6 8,908 (6) 12,274 - 12,274 Insurance service result 245 2,936 1,594 743 - 2,567 539 1 8,625 116 8,741 Net financial result from insurance finance income and expense - 2,766 (16,194) (20) - - 244 - (13,204) (91) (13,295) - Net finance income/(expense) from insurance contracts - 2,825 (16,194) (19) - - 648 - (12,740) (91) (12,831) - Net finance expense from reinsurance contracts - (59) - (1) - - (404) - (464) - (464) Investment income using the effective interest rate method 11 84 103 322 - 203 79 27 829 288 1,117 Net fair value gains on financial instruments at fair value through profit or loss 2 3,303 17,497 2 59 42 - - 20,905 5,234 26,139 Fair value adjustments to liabilities under investment contracts - (2,810) (1,159) - - - - - (3,969) 75 (3,894) Third party interest: fair value adjustments to liabilities under investment contracts - - - - - - - - - (4,317) (4,317) Net insurance and investment results 258 6,279 1,841 1,047 59 2,812 862 28 13,186 1,305 14,491 Fee income from administration businesses 10,341 228 1,605 - - 38 - 2,492 14,704 (105) 14,599 Vitality income - - - - - 31 298 5,880 6,209 (590) 5,619 Net banking fee and commission income - - - - 1,815 - - (91) 1,724 375 2,099 - Banking fee and commission income - - - - 2,763 - - - 2,763 (14) 2,749 - Banking fee and commission expense - - - - (948) - - (91) (1,039) 389 (650) Net banking interest and similar income - - - - 1,255 - - - 1,255 1 1,256 - Banking interest and similar income using the effective interest rate - - - - 2,570 - - - 2,570 - 2,570 - Banking interest and similar expense using the effective interest rate - - - - (1,315) - - - (1,315) 1 (1,314) Other income 2,054 193 1 77 58 - - 16,062 18,445 (14,635) 3,810 Non-insurance revenue and income 12,395 421 1,606 77 3,128 69 298 24,343 42,337 (14,954) 27,383 Net income 12,653 6,700 3,447 1,124 3,187 2,881 1,160 24,371 55,523 (13,649) 41,874 Non-insurance acquisition costs - - (503) - - - - (197) (700) 364 (336) Expected credit losses - - - - (350) - - - (350) - (350) Marketing and administration expenses (8,023) (828) (787) (169) (2,467) (985) (377) (24,690) (38,326) 15,751 (22,575) Share of net profits from equity-accounted investments (1) - - 58 - - (1) 1,547 1,603 (80) 1,523 Normalised profit/(loss) from operations 4,629 5,872 2,157 1,013 370 1,896 782 1,031 17,750 2,386 20,136 Investment income earned on shareholder investments and cash 104 - 4 12 - - 2 166 288 (288) - Intercompany investment income - - - - - - - 1,367 1,367 (1,367) - Net fair value gains on financial assets at fair value through profit or loss - 178 48 - - - - 89 315 (315) - Gain from dilution of equity accounted investments - - - 211 - - - - 211 50 261 Amortisation of intangibles from business combinations - - - (30) - - - (85) (115) 115 - Market rentals related to Head Office building adjusted for finance costs and depreciation - - - - - - - (33) (33) 33 - 1DP Lease termination gains - - - - - - - 1,463 1,463 (1,463) - Restructuring costs - - - - - - - (1) (1) 1 - Interest expenses on borrowings and lease liabilities (3) (1) - - - (24) (65) (1,396) (1,489) (328) (1,817) Intercompany finance expenses on borrowings (460) - - - - - (463) (444) (1,367) 1,367 - Foreign exchange losses - - - - - - - (123) (123) - (123) Profit/(loss) before income tax 4,270 6,049 2,209 1,206 370 1,872 256 2,034 18,266 191 18,457 Income tax expense (1,138) (1,615) (1,074) (257) (152) (469) (97) (246) (5,048) (191) (5,239) Profit/(loss) for the year 3,132 4,434 1,135 949 218 1,403 159 1,788 13,218 - 13,218 Profit attributable to: Ordinary shareholders 3,132 4,434 1,135 949 218 1,403 159 1,702 13,132 - 13,132 Preference shareholders - - - - - - - 86 86 - 86 Non-controlling interest - - - - - - - - - - - Segment information IFRS REPORTING ADJUSTMENTS # Public -- 9 of 18 -- VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST R million June 2026 December 2025 June 2025 December 2024 June 2024 VIF1 Life 35,749 32,654 27,910 27,082 24,138 Invest 14,713 15,194 13,346 12,715 11,675 APE2 Life 803 411 735 355 804 Invest 2,901 1,467 2,535 1,234 2,411 VNB1 Life 241 138 113 94 225 Invest 228 163 349 145 256 2 APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium Investment business) in relation to New Business only, and excludes any addition to Existing Business premiums arising from servicing increases and ACIs. Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for December 2016 and later periods. 1 These VIF and VNB numbers are after allowing for the Cost of required Capital. 10 Results split Life and Invest # Public -- 10 of 18 -- Group Shareholder Free Cash Movement R millions FY2026 H1 FY2026 FY2025 H1 FY2025 FY2024 Cash Generated from In-Force Before Financing and Tax 21,438 9,652 17,655 8,319 14,617 New Business Net of External Financing (7,318) (3,679) (6,791) (3,506) (6,823) Tax Paid (2,825) (1,337) (1,867) (758) (1,522) Operating Cash Flow 11,295 4,636 8,997 4,055 6,272 New Initiatives (76) 51 (843) (727) (1,025) Business Development and Other (1,148) (609) (1,016) (595) (1,580) Finance Cost Paid (1,568) (823) (1,691) (899) (1,566) Dividends Paid (2,205) (1,407) (1,708) (1,073) (1,270) Financing and Matching Initiatives (1,398) (722) (539) (236) (496) Transactions with Debt Holders (Excl. Finance Costs) (2,058) (182) (1,572) (491) 1,130 1 Discovery Place Transaction (1) (6) - - - - Purchase of Property (4,053) - - - - Debt Funding 4,047 - - - - Once-offs (2) 801 - - - - Movement in Shareholder Free Cash 3,637 944 1,629 35 1,465 Remove ordinary dividends paid in period 2,119 1,361 1,614 1,026 1,179 Add ordinary dividends payable in respect of period (2,621) (758) (1,949) (588) (1,465) Movement in Shareholder Free Cash – Dividend Accrual Basis (3) 3,135 1,547 1,294 473 1,179 Movement in Shareholder Free Cash - Excl Transactions with Borrowers and Financing and Matching Initiatives 9,299 3,255 5,448 1,835 2,101 Operating Cash Flow 11,295 4,636 8,997 4,055 6,272 IFRS Normalised Profit from Operations net of Tax Expense (4) 13,226 6,508 11,277 5,269 9,170 Cash Conversion Ratio (4) 85% 71% 80% 77% 68% Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period R millions FY2026 H1 FY2026 FY2025 H1 FY2025 FY2024 Profit for the period 13,218 5,759 9,559 4,329 7,549 Reverse non-cash profit items: Share of net (profits)/losses from equity accounted investments (1,603) (732) (1,266) (425) (1,031) Losses/(gains) from dilution of equity accounted investments (211) - 32 26 (22) Depreciation and amortisation 2,313 1,127 2,177 1,074 2,160 Impairment of intangible assets 69 28 131 21 45 Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) - - - - - Movement in contract assets (173) (252) (359) (462) (640) Amortisation of intangibles from business combinations - - - - - Non cash impact of Vitality Health DAC (500) (219) (510) (217) (411) Non-cash fair value gains on financial assets (315) (125) (21) (47) (87) Non-cash forex gains / losses - - 20 - 0 Bank interest income incurred to cash (362) (137) (152) (277) - Gains or losses on lease modification (1,463) - - - - Other non-cash adjustments to profit 18 (89) 57 (22) (151) Adjustments from IFRS to EV ANW: Increase in Negative Reserves and Invest DAC (Net of tax) (2,222) (1,186) (3,181) (1,487) (4,733) Exchange rate movements on Vitality Life Negative Reserves (975) (774) 481 206 (385) Other adjustments to arrive at EV ANW 1,002 59 (279) 404 1,644 Incurred to Cash basis: Rent Paid (627) (303) (580) (329) (511) Finance Costs Paid (2,678) (1,350) (2,877) (1,494) (2,603) Finance Costs Accrued 3,395 1,724 3,324 1,711 3,097 Taxation paid (2,825) (1,337) (1,867) (758) (1,522) Taxation Accrued 2,826 1,221 2,049 654 1,093 Investing Activities: Purchase of property and equipment (4,533) (145) (294) (120) (414) Proceeds from disposal of property and equipment 2 2 3 3 28 Purchase of intangible assets (1,510) (735) (1,682) (875) (1,789) Proceeds from disposal of intangible assets 2 - - 0 - Increase in investment in associate 467 (0) (316) 0 (0) Increase in investment & dividends from equity accounted investment 539 (3) 463 (11) 287 Cash proceeds from CMT transaction - - - (304) - Financing Activities: Increase in borrowings 13,049 2,592 3,264 1,765 2,005 Repayment of borrowings (11,061) (2,774) (4,836) (2,257) (874) Dividends paid to ordinary shareholders (2,119) (1,363) (1,614) (1,026) (1,179) Dividends paid to preference shareholders (86) (44) (93) (47) (91) Share Issue (Net of Share Issue Costs) - - - - - Movement in Shareholder Free Cash 3,637 944 1,629 35 1,465 Notes "Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in working capital are not allowed for in the estimate. 1) The impact on shareholder free cash from the “1 Discovery Place Transaction” is neutral, as the purchase of the property was fully funded with debt. The debt funding for the “1 Discovery Place Transaction” should be considered with the disclosed “Transactions with Debt Holders (Excl. Finance Costs)” line to represent total debt holder transactions for the Group from a shareholder free cash perspective. 2) The once-offs relate to CMT sale proceeds. 3) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For the year ended 30 June 2026, the interim declared dividend of R756m, per the interim financial results, and the final declared dividend of R1 863m, per the annual financial results, are used as the total dividend accrued in respect of the twelve-month period. 4) Cash conversion is calculated as Operating Cash Flow per the Group shareholder free cash movement, divided by Normalised Profit from Operations (IFRS total, excluding the IFRS Reporting Adjustments for shareholder investment income and fair value gains/(losses)) net of Income tax expense (IFRS total) per A.1 Segment Information. For June 2026, Normalised Profit from Operations has been further adjusted to exclude the once-off net-of-tax gain arising on the 1DP lease termination, resulting in a more representative measure of underlying cash conversion. # Internal -- 11 of 18 -- Reconciliation of operating profit to normalised operating profit for the year ended 30 June 2026 Group Group R million Year ended June 2026 Year ended June 2025 % change Operating profit 18,613 14,587 28% Share of net profits from equity accounted investments 1,523 1 215 Impairment of goodwill - 20 Normalised profit from operations per Segment information (IFRS total) 20,136 15,822 27% Normalised profit adjustments (2 386) ( 612) Investment income earned on shareholder investments and cash ( 288) ( 352) Difference between market related rental and depreciation and finance costs (Head office) ( 230) ( 205) Tax specific to policyholder tax funds ( 191) ( 152) Net fair value gains on financial assets at fair value through profit or loss ( 315) ( 105) Amortisation of intangibles from business combinations 115 122 Restructuring costs ( 1) 80 CMT disposal costs 50 - 1DP lease termination (1 526) - Normalised profit from operations 17,750 15,210 17% 12 Op Profit recon # Public -- 12 of 18 -- Discovery Bank additional performance metrics for the six months ended 30 June 2026 2026 H2 2026 H1 2025 H2 2025 H1 2024 H2 2024 H1 2023 H2 2023 H1 Profitability and Efficiency Retail Net Interest Margin (NIM)* 8.30% 8.35% 8.85% 9.65% 10.19% 10.06% 9.53% 9.37% Asset Quality Non-Performing Loan (NPL) Ratio 4.82% 4.76% 4.79% 4.92% 5.41% 5.84% 5.02% 4.16% Capital Adequacy Common Equity Tier 1 (CET1) Ratio 17.00% 15.19% 16.31% 16.67% 17.63% 17.07% 16.82% 16.47% Liquidity Loan-to-Deposit Ratio (LDR) 47.39% 42.96% 39.37% 37.05% 35.72% 34.48% 36.08% 23.46% *Excludes interest on bonds # Public -- 13 of 18 -- NAV PER ENTITY for the year ended June 2026 Covered businesses June 2026 NAV before adjustment to shareholder funds Health and Vitality 2,069 Life and Invest 44,345 VitalityHealth 10,155 VitalityLife 6,919 Non-covered businesses Bank, including DCS intangible asset and goodwill 9,289 Insure 2,932 PAHI 8,155 CMT 621 Limited (7,067) Other 5,243 Total NAV 82,661 # Public -- 14 of 18 -- Normalised Return on Equity FY2026 FY2025 FY2024 EARNINGS Net profit - attributable to: 13,218 9,558 7,549 - Ordinary shareholders 13,132 9,471 7,468 A - Preference shareholders 86 93 91 - Non-controlling interest - (6) (10) Earnings adjustments for ordinary shareholders (1,337) 310 43 C=B-A Normalised headline earnings 11,795 9,781 7,511 B EQUITY Opening total equity 65,699 54,451 47,242 - Insurance Finance Reserve (2,928) (4,832) (6,312) - Perpetual preference share capital 779 779 779 - Non-controlling interest (5) - 4 - Other equity 67,853 58,504 52,771 D Adjusted opening equity 67,853 58,504 52,771 E=D Closing total equity 82,661 65,699 54,451 - Insurance Finance Reserve 5,489 (2,928) (4,832) - Perpetual preference share capital 779 779 779 - Non-controlling interest (7) (5) - - Other equity 76,400 67,853 58,504 F Adjusted closing equity 76,400 67,853 58,504 G=F Normalised adjusted closing equity 75,063 68,163 58,547 H=G+C Average normalised equity 71,458 63,334 55,659 I=(H+E)/2 RETURN ON EQUITY Full-year Normalised return on equity (annualised) 16.5% 15.4% 13.5% =B/I # Public -- 15 of 18 -- RECONCILIATION OF KEY IFRS 17 METRICS TO EV for the year ended 30 June 2026 SA Life & Invest Segment UK Life Segment Twelve months ended 30 June 2026 IFRS 17 CSM plus Risk Adjustment balance - Gross of tax 44,976 9,194 Reconciling items: IFRS 17 LRC and LIC net of backing assets1 41,510 10,841 Adjust for tax2 (23,119) (1,999) Change to Risk Discount Rate (17,007) (2,990) Limit to EV Term (877) - VIF on investment contracts measured under IFRS 9 4,673 - Other IFRS and VIF methodology differences3 2,076 200 Cost of Capital (1,771) (776) Net value of in-force of covered business (after cost of capital) 50,462 14,469 SA Life & Invest Segment UK Life Segment IFRS 17 new business value - Gross of tax 2,677 1,413 Reconciling items: Adjust for tax2 (835) (520) Change to Risk Discount Rate (685) (484) Limit to EV Term (51) - VNB on investment contracts measured under IFRS 9 55 - Other IFRS and VNB methodology differences4 (606) 153 Cost of Capital (86) (159) Net value of new business of covered business (after cost of capital) 469 403 4) Methodology differences in the contract boundary applied to new business as well as differences in economic and non-economic assumptions. For UK Life, this also includes the exclusion of the impact of new reinsurance contracts attaching to the in-force book in the year, which is considered part of the opening initial recognition value, but not included in the VNB. The following table reconciles the IFRS 17 CSM plus Risk Adjustment balances for the SA Life GMM, SA Life PAA, SA Invest GMM, SA Invest VFA and UK Life GMM portfolios to their Value of In-Force net of Cost of Capital: 1) This item adds back the Liability for Remaining Coverage and the Liability for Incurred Claims to derive the total IFRS 17 BEL, and then removes the portion of the BEL backed by tangible assets. 2) EV is calculated on a net of tax basis. Tax calculations cover different insurance tax funds, tax credits and IFRS 17 transitional tax arrangements. 3) This item includes the Group Life VIF & the EV impact of other risk mitigating PAA contracts, and reflects the cost of internal asset- liability matching structures within the EV basis. The following table reconciles the IFRS 17 new business value, i.e., the initial recognition values for the SA Life GMM, SA Invest GMM, SA Invest VFA and UK Life GMM portfolios, to the Value of New Business net of Cost of Capital. # Public -- 16 of 18 -- # Public -- 17 of 18 -- # Public -- 18 of 18 --